ScreenerHero
LIKLIMES Schlosskliniken AG
XETRA · DE · Healthcare · Medical Care Facilities · limes-schlosskliniken.de
570.00EUR0.00%Mkt Cap: 184.60M $P/E: 29.84

LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, Italy, and Liechtenstein. The company focuses on the treatment of stress-related illne…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA Inhaber-Aktien o.N.
$28.29BUSDP/E 16.7
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG & Co. KGaA
$11.94BUSDP/E 12.3
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
Emeis SA
$2.46BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5

Key Statistics

Company
Market Cap184.60M $
Enterprise Value186.70M $
Revenue (TTM)54.34M $
Gross Profit49.93M $
Net Income (TTM)6.19M $
Revenue/Share182.39 USD
Last Price570.00 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees183
CountryDE
SectorHealthcare
IndustryMedical Care Facilities
ISINDE000A0JDBC7
Valuation
P/E (Trailing)29.84
P/E (Forward)12.52
PEG—
EV/EBITDA13.46
EV/Revenue3.44
P/S3.40
P/B6.71
EPS (TTM)19.10
EPS (Forward)45.54
52W Range
316.0093% of range590.00
52W High590.00 EUR
52W Low316.00 EUR
Profitability
Gross Margin91.88%
Oper. Margin16.29%
EBITDA Margin25.53%
Profit Margin11.39%
ROE22.50%
ROA12.61%
Growth
Revenue Growth43.10%
Earnings Growth79.70%
Cash Flow & Leverage
Operating CF10.62M $
CapEx (TTM)9.39M $
FCF Margin-4.42%
FCF Yield-1.30%
Net Debt454.28K $
Net Debt/EBITDA0.03
Balance Sheet
Debt/Equity0.42
Current Ratio4.13
Quick Ratio3.96
Book Value/Sh84.95 EUR
Cash/Share34.62 EUR
Dividends
Fwd Div Rate10.00 EUR
Trail. Div Rate10.00 EUR
Div. Yield1.75%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 22, 2026
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)697.50 EUR
Upside (mean)+22.4%
Target Range585.00 EUR – 810.00 EUR
€585.00+22.4% to mean€810.00
# Analysts2
Ownership
Shares Out.297.95K
Float—
Insiders74.43%
Institutions7.25%
Technical
SMA 50549.76 (+3.7%)
SMA 200469.67 (+21.4%)
Beta0.88
S&P 52W Chg18.16%
Avg Vol (30d)96
Avg Vol (10d)138
Technical Indicators
RSI (14)54.1
MACD8.3983
MACD Signal9.5825
MACD Hist.-1.1842
BB Upper589.62 EUR
BB Middle566.25 EUR
BB Lower542.88 EUR
BB Width8.25%
ATR (14)13.63 EUR
Vol Ratio (20d)0.08x